U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Hanover Foods Corporation - 612551 - 07/21/2022
  1. Warning Letters

CLOSEOUT LETTER

Hanover Foods Corporation MARCS-CMS 612551 —

Delivery Method:
VIA UPS
Product:
Food & Beverages
Recipient:
Recipient Name
Jeffrey Warehime
Recipient Title
CEO
Hanover Foods Corporation

1486 York Street
Hanover, PA 17331
United States

Issuing Office:
Division of Human and Animal Food Operations East II

United States

Dear Mr. Warehime,

The Food & Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter 612551, dated March 26, 2021. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations, or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Andrew Howard
/S/
Consumer Safety Officer/Compliance Officer
Office of Human and Animal Food East II
Baltimore District Office
U.S. Food and Drug Administration
Tel: 410-779-5125
Cel: 240-506-1758
Andrew.Howard@fda.hhs.gov

Back to Top